Your browser doesn't support javascript.
loading
Self-organization, quality control, and preclinical studies of human iPSC-derived retinal sheets for tissue-transplantation therapy.
Watari, Kenji; Yamasaki, Suguru; Tu, Hung-Ya; Shikamura, Masayuki; Kamei, Tatsuya; Adachi, Hideki; Tochitani, Tomoaki; Kita, Yasuyuki; Nakamura, Aya; Ueyama, Kazuki; Ono, Keiichi; Morinaga, Chikako; Matsuyama, Take; Sho, Junki; Nakamura, Miyuki; Fujiwara, Masayo; Hori, Yoriko; Tanabe, Anna; Hirai, Rina; Terai, Orie; Ohno, Osamu; Ohara, Hidetaka; Hayama, Tetsuya; Ikeda, Atsushi; Nukaya, Daiki; Matsushita, Keizo; Takahashi, Masayo; Kishino, Akiyoshi; Kimura, Toru; Kawamata, Shin; Mandai, Michiko; Kuwahara, Atsushi.
Afiliación
  • Watari K; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Yamasaki S; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Tu HY; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Chuo-ku, Kobe, 650-0047, Japan.
  • Shikamura M; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Chuo-ku, Kobe, 650-0047, Japan.
  • Kamei T; Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation at Kobe, Chuo-ku, Kobe, 650-0047, Japan.
  • Adachi H; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Tochitani T; Preclinical Research Unit, Research Division, Sumitomo Pharma Co., Ltd., Konohana-ku, Osaka, 554-0022, Japan.
  • Kita Y; Preclinical Research Unit, Research Division, Sumitomo Pharma Co., Ltd., Konohana-ku, Osaka, 554-0022, Japan.
  • Nakamura A; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Ueyama K; Technology Research & Development Division, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Ono K; Technology Research & Development Division, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Morinaga C; Technology Research & Development Division, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Matsuyama T; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Chuo-ku, Kobe, 650-0047, Japan.
  • Sho J; RIKEN Program for Drug Discovery and Medical Technology Platforms, RIKEN Cluster for Science, Technology and Innovation Hub., Saitama, 351-0198, Japan.
  • Nakamura M; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Chuo-ku, Kobe, 650-0047, Japan.
  • Fujiwara M; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Chuo-ku, Kobe, 650-0047, Japan.
  • Hori Y; Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation at Kobe, Chuo-ku, Kobe, 650-0047, Japan.
  • Tanabe A; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Hirai R; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Terai O; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Ohno O; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Ohara H; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Hayama T; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Ikeda A; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Nukaya D; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Matsushita K; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Takahashi M; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Kishino A; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Kimura T; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Chuo-ku, Kobe, 650-0047, Japan.
  • Kawamata S; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Chuo-ku, Kobe, 650-0047, Japan.
  • Mandai M; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
  • Kuwahara A; Regenerative & Cellular Medicine Kobe Center, Sumitomo Pharma Co., Ltd., Chuo-ku, Kobe, 650-0047, Japan.
Commun Biol ; 6(1): 164, 2023 02 10.
Article en En | MEDLINE | ID: mdl-36765170
ABSTRACT
Three-dimensional retinal organoids (3D-retinas) are a promising graft source for transplantation therapy. We previously developed self-organizing culture for 3D-retina generation from human pluripotent stem cells (hPSCs). Here we present a quality control method and preclinical studies for tissue-sheet transplantation. Self-organizing hPSCs differentiated into both retinal and off-target tissues. Gene expression analyses identified the major off-target tissues as eye-related, cortex-like, and spinal cord-like tissues. For quality control, we developed a qPCR-based test in which each hPSC-derived neuroepithelium was dissected into two tissue-sheets inner-central sheet for transplantation and outer-peripheral sheet for qPCR to ensure retinal tissue selection. During qPCR, tissue-sheets were stored for 3-4 days using a newly developed preservation method. In a rat tumorigenicity study, no transplant-related adverse events were observed. In retinal degeneration model rats, retinal transplants differentiated into mature photoreceptors and exhibited light responses in electrophysiology assays. These results demonstrate our rationale toward self-organizing retinal sheet transplantation therapy.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Degeneración Retiniana / Células Madre Pluripotentes / Células Madre Pluripotentes Inducidas Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Degeneración Retiniana / Células Madre Pluripotentes / Células Madre Pluripotentes Inducidas Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Japón